Our results showed that TCD4+CD11b+ may have an effective participation in the process of endothelium adhesion and occlusive vessel crisis regardless of reticulocytosis, thrombocytosis, and death risk in contrast to the TCD8+ lymphocyte that had a low expression of Mac-1 compared to the HD group. This evidence concerns the gene ITGAM and thrombocytosis disease.